Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

beta-Galactosidase

A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. [from MeSH]

MedGen UID:
550
Concept ID:
C0005220
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
2.

Able

MedGen UID:
721424
Concept ID:
C1299581
Finding
3.

Papillary thyroid carcinoma

Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95% of all thyroid cancer cases. The remaining cancers originate from parafollicular cells (medullary thyroid cancer, MTC; 155240). NMTC is classified into 4 groups: papillary, follicular (188470), Hurthle cell (607464), and anaplastic. Approximately 5% of NMTC is hereditary, occurring as a component of a familial cancer syndrome (e.g., familial adenomatous polyposis, 175100; Carney complex, 160980) or as a primary feature (familial NMTC or FNMTC). Papillary thyroid cancer (PTC) is the most common histologic subtype of FNMTC, accounting for approximately 85% of cases (summary by Vriens et al., 2009). PTC is characterized by distinctive nuclear alterations including pseudoinclusions, grooves, and chromatin clearing. PTCs smaller than 1 cm are referred to as papillary microcarcinomas. These tumors have been identified in up to 35% of individuals at autopsy, suggesting that they may be extremely common although rarely clinically relevant. PTC can also be multifocal but is typically slow-growing with a tendency to spread to lymph nodes and usually has an excellent prognosis (summary by Bonora et al., 2010). Genetic Heterogeneity of Susceptibility to Nonmedullary Thyroid Cancer Other susceptibilities to nonmedullary thyroid cancer include NMTC2 (188470), caused by mutation in the SRGAP1 gene (606523); NMTC3 (606240), mapped to chromosome 2q21; NMTC4 (616534), caused by mutation in the FOXE1 gene (602617); and NMTC5 (616535), caused by mutation in the HABP2 gene (603924). A susceptibility locus for familial nonmedullary thyroid carcinoma with or without cell oxyphilia (TCO; 603386) has been mapped to chromosome 19p. [from GTR]

MedGen UID:
66773
Concept ID:
C0238463
Neoplastic Process
4.

Endoglycosidases

MedGen UID:
760845
Concept ID:
C3537242
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
5.

Lactogest

MedGen UID:
327777
Concept ID:
C1564492
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
6.

Dairyaid

MedGen UID:
289840
Concept ID:
C1564491
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
7.

Lactrase

MedGen UID:
152475
Concept ID:
C0721296
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
8.

Lactaid

MedGen UID:
149213
Concept ID:
C0733877
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
9.

General drug type

A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product. [from NCI]

MedGen UID:
8496
Concept ID:
C0013227
Pharmacologic Substance
10.

Glycosidase

covering the sugar hydrolases. [from CRISP]

MedGen UID:
5349
Concept ID:
C0017976
Amino Acid, Peptide, or Protein; Enzyme; Pharmacologic Substance
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center